Chemtrade Logistics Income Fund (CHE-UN) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
17 Nov, 2025Executive summary
Achieved record quarterly Adjusted EBITDA of $151.2 million in Q3 2025, up 10.2% year-over-year, with double-digit revenue and distributable cash growth, driven by operational excellence, higher selling prices, and volumes in key products.
Both Sulphur & Water Chemicals (SWC) and Electrochemicals (EC) segments contributed to strong results, with a weaker Canadian dollar positively impacting revenue and Adjusted EBITDA.
Net earnings declined 29.5% year-over-year to $42.4 million due to higher corporate costs, one-time items, and debenture fair value changes.
Vision 2030 targets 5%-10% annual Adjusted EBITDA and distributable cash growth, aiming for mid-cycle EBITDA of $550-$600 million by 2030.
Financial highlights
Q3 2025 revenue was $532.8 million, up 12.4% year-over-year; Adjusted EBITDA reached $151.2 million, up 10.2%.
Distributable cash after maintenance capex was $77.8 million, up 18% year-over-year; per-unit distributable cash rose 24.4% to $0.69.
Net debt at quarter-end was $941.1 million, with net debt to LTM Adjusted EBITDA stable at 1.8x and liquidity of $484 million.
Cash flow from operating activities for Q3 2025 was $155.5 million, up 8.5% year-over-year.
Payout ratio for Q3 2025 was 25%, and 32% on a trailing 12-month basis.
Outlook and guidance
Raised full-year 2025 Adjusted EBITDA guidance to above $503 million, surpassing 2023's $502.6 million, with favorable market conditions and resilience despite global trade tensions.
Implied 2025 payout ratio expected at ~37% or less.
Guidance assumes strong MECU netbacks, stable sodium chlorate volumes, and favorable FX rates; excludes Polytec acquisition earnings due to regulatory delays.
2026 outlook includes a North Vancouver turnaround, normalization in merchant acid, continued chlorine weakness, and growth from Polytec, Thatcher, and organic projects.
Vision 2030 targets mid-cycle annual Adjusted EBITDA of $550–$600 million by 2030.
Latest events from Chemtrade Logistics Income Fund
- Record 2025 results and strong 2026 outlook, driven by acid, water solutions, and acquisitions.CHE-UN
Q4 202526 Feb 2026 - 2024 EBITDA guidance raised to $430–$460M after strong Q2; SWC up, EC hit by caustic soda prices.CHE-UN
Q2 20241 Feb 2026 - Raised 2024 Adjusted EBITDA guidance to $445–$460M after resilient Q3 and strong cash flow.CHE-UN
Q3 202414 Jan 2026 - 2026 Adjusted EBITDA is projected at $485–$525 million, with a payout ratio near 45%.CHE-UN
Guidance Presentation8 Jan 2026 - 2024 Adjusted EBITDA hit $470.8M; 2025 guidance is $430–$460M with growth focus.CHE-UN
Q4 20241 Dec 2025 - Raised 2025 guidance and Vision 2030 target strong EBITDA growth and long-term value.CHE-UN
Q1 202526 Nov 2025 - Q2 2025 delivered double-digit growth, raised guidance, and announced the Polytec acquisition.CHE-UN
Q2 202523 Nov 2025 - 2025 Adjusted EBITDA is forecast at $430M–$460M, with strong growth and ESG focus.CHE-UN
Investor Presentation17 Jun 2025 - Strong market leadership, robust financials, and ESG focus drive growth and unitholder value.CHE-UN
Investor Presentation17 Jun 2025